Jomana Musmar | CEO
AMR Strategic Coalition

Dr. Jomana Musmar is a distinguished global policy expert and result-oriented leader with decades of intimate government experience within the U.S. Departments of Health and Human Services (HHS), Defense (DoD), and Agriculture (USDA). She excels in cross-functional coordination, strategic planning, operational design, and policy execution. Dr. Musmar is the Founder of Advisors of Global Health (AGH), a consulting 􀏐irm specializing in government and external affairs, policy and product development, and coalition building. She also Co-Founded and serves as the Chief Executive Of􀏐icer of the Antimicrobial Strategic Coalition (ASC), an independent organization that leads cross-sector coordination to establish a uni􀏐ied stance on US-based policy positions on Antimicrobial Resistance (AMR) across the One Health spectrum. Dr. Musmar concurrently serves as Leadership Council Member at The National Institute of Antimicrobial Resistance Research and Education, on several global AMR scientific and planning committees including the National Academies of Sciences, Engineering, and Medicine, World One Health Congress, Global Health Security Network, AMR Narrative, and is an Honorary Senior Lecturer at the University of Bristol in the UK. Renowned for simplifying complex topics with expertise and diplomacy, Dr. Musmar has spearheaded innovative solutions to global One Health challenges, shaped impactful policies, and advanced national and international missions. As the Executive Director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) for over a decade, she 􀏐irst established and led the PACCARB's operations liaising with over 600 experts in human, animal, and environmental domains across government, industry, and academia. Her efforts culminated in the development of critical recommendations addressing AMR and interrelated One Health issues, in􀏐luencing both domestic and global health strategies. In her tenure as Deputy Director of Strategic Initiatives for the Of􀏐ice of Infectious Diseases and HIV/AIDS Policy within the Of􀏐ice of the Secretary at HHS, Dr. Musmar oversaw the formulation and implementation of national health strategies for vaccines and a range of infectious diseases including HIV/AIDS, sexually transmitted infections, viral hepatitis, and the regulatory policies that govern them. Her leadership and technical expertise facilitated the development of interagency and executive level task forces and streamlined implementation of operations during national emergencies, including responses to the COVID-19 pandemic, and initiatives to combat congenital syphilis and childhood vaccination disruptions. Dr. Musmar holds a Ph.D. in Biodefense and International Security from George Mason University, a Master's degree in Biomedical Science policy and Advocacy from Georgetown University, and is a Lean Six Sigma Black Belt. Fluent in English and Arabic, she is a sought-after speaker and advisor, having represented the United States at premier global health conferences. Her published works on AMR, pandemic preparedness, and global health security policy underscore her reputation as a thought leader and innovator in public health and biodefense.